Sign In
Claims against Hyderabad based Dr Reddy's over Revlimid in US dismissed
Cipla's automation spends to continue for 3-4 years
Hetero's oral antiviral treatment candidate gets WHO PQ approval
Indian pharma sector set for 'volume to value leadership' journey in 2023
DCGI approves BE's 14-valent pneumococcal conjugate vaccine
Healthtech startup PharmEasy lays off more employees
Aurobindo Pharma inks pact with IMT Hyderabad
Tata 1mg launches drone delivery in Dehradun
No pressure to speed up vax development: Bharat Bio
Making Indian drugs globally competitive
Biocon arm features in Asia IP Elite list
John Shaw, former Biocon VC passes away
